284 related articles for article (PubMed ID: 27959966)
1. X-Linked Alport Dogs Demonstrate Mesangial Filopodial Invasion of the Capillary Tuft as an Early Event in Glomerular Damage.
Clark SD; Nabity MB; Cianciolo RE; Dufek B; Cosgrove D
PLoS One; 2016; 11(12):e0168343. PubMed ID: 27959966
[TBL] [Abstract][Full Text] [Related]
2. α1β1 integrin/Rac1-dependent mesangial invasion of glomerular capillaries in Alport syndrome.
Zallocchi M; Johnson BM; Meehan DT; Delimont D; Cosgrove D
Am J Pathol; 2013 Oct; 183(4):1269-1280. PubMed ID: 23911822
[TBL] [Abstract][Full Text] [Related]
3. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
Cosgrove D; Dufek B; Meehan DT; Delimont D; Hartnett M; Samuelson G; Gratton MA; Phillips G; MacKenna DA; Bain G
Kidney Int; 2018 Aug; 94(2):303-314. PubMed ID: 29759420
[TBL] [Abstract][Full Text] [Related]
4. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.
Zeisberg M; Khurana M; Rao VH; Cosgrove D; Rougier JP; Werner MC; Shield CF; Werb Z; Kalluri R
PLoS Med; 2006 Apr; 3(4):e100. PubMed ID: 16509766
[TBL] [Abstract][Full Text] [Related]
5. Pathogenicity of a Human Laminin
Funk SD; Bayer RH; Malone AF; McKee KK; Yurchenco PD; Miner JH
J Am Soc Nephrol; 2018 Mar; 29(3):949-960. PubMed ID: 29263159
[TBL] [Abstract][Full Text] [Related]
6. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
[TBL] [Abstract][Full Text] [Related]
7. Upregulated expression of integrin α1 in mesangial cells and integrin α3 and vimentin in podocytes of Col4a3-null (Alport) mice.
Steenhard BM; Vanacore R; Friedman D; Zelenchuk A; Stroganova L; Isom K; St John PL; Hudson BG; Abrahamson DR
PLoS One; 2012; 7(12):e50745. PubMed ID: 23236390
[TBL] [Abstract][Full Text] [Related]
8. Endothelin A receptor activation on mesangial cells initiates Alport glomerular disease.
Dufek B; Meehan DT; Delimont D; Cheung L; Gratton MA; Phillips G; Song W; Liu S; Cosgrove D
Kidney Int; 2016 Aug; 90(2):300-310. PubMed ID: 27165837
[TBL] [Abstract][Full Text] [Related]
9. Ramipril therapy in integrin α1-null, autosomal recessive Alport mice triples lifespan: mechanistic clues from RNA-seq analysis.
Madison J; Wilhelm K; Meehan DT; Gratton MA; Vosik D; Samuelson G; Ott M; Fascianella J; Nelson N; Cosgrove D
J Pathol; 2024 Mar; 262(3):296-309. PubMed ID: 38129319
[TBL] [Abstract][Full Text] [Related]
10. Glomerular basement membrane deposition of collagen α1(III) in Alport glomeruli by mesangial filopodia injures podocytes via aberrant signaling through DDR1 and integrin α2β1.
Madison J; Wilhelm K; Meehan DT; Delimont D; Samuelson G; Cosgrove D
J Pathol; 2022 Sep; 258(1):26-37. PubMed ID: 35607980
[TBL] [Abstract][Full Text] [Related]
11. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K
Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810
[TBL] [Abstract][Full Text] [Related]
12. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice.
Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O
Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional, non-necrotizing glomerular crescents are the critical pathology in X-linked Alport syndrome mouse model harboring nonsense mutation of human COL4A5.
Song JY; Saga N; Kawanishi K; Hashikami K; Takeyama M; Nagata M
Sci Rep; 2020 Nov; 10(1):18891. PubMed ID: 33144651
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of glomerular collagen IV immunofluorescence studies in male patients with X-linked Alport syndrome.
Massella L; Gangemi C; Giannakakis K; Crisafi A; Faraggiana T; Fallerini C; Renieri A; Muda AO; Emma F
Clin J Am Soc Nephrol; 2013 May; 8(5):749-55. PubMed ID: 23371956
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS).
Rao VH; Lees GE; Kashtan CE; Nemori R; Singh RK; Meehan DT; Rodgers K; Berridge BR; Bhattacharya G; Cosgrove D
Kidney Int; 2003 May; 63(5):1736-48. PubMed ID: 12675849
[TBL] [Abstract][Full Text] [Related]
16. Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.
Tanaka M; Asada M; Higashi AY; Nakamura J; Oguchi A; Tomita M; Yamada S; Asada N; Takase M; Okuda T; Kawachi H; Economides AN; Robertson E; Takahashi S; Sakurai T; Goldschmeding R; Muso E; Fukatsu A; Kita T; Yanagita M
J Clin Invest; 2010 Mar; 120(3):768-77. PubMed ID: 20197625
[TBL] [Abstract][Full Text] [Related]
17. Laminin-1 reexpression in Alport mouse glomerular basement membranes.
Abrahamson DR; Prettyman AC; Robert B; St John PL
Kidney Int; 2003 Mar; 63(3):826-34. PubMed ID: 12631063
[TBL] [Abstract][Full Text] [Related]
18. A novel model of autosomal dominant Alport syndrome in Dalmatian dogs.
Hood JC; Huxtable C; Naito I; Smith C; Sinclair R; Savige J
Nephrol Dial Transplant; 2002 Dec; 17(12):2094-8. PubMed ID: 12454218
[TBL] [Abstract][Full Text] [Related]
19. Role of distinct type IV collagen networks in glomerular development and function.
Harvey SJ; Zheng K; Sado Y; Naito I; Ninomiya Y; Jacobs RM; Hudson BG; Thorner PS
Kidney Int; 1998 Dec; 54(6):1857-66. PubMed ID: 9853250
[TBL] [Abstract][Full Text] [Related]
20. A unique evolution of the kidney phenotype in a patient with autosomal recessive Alport syndrome.
Vischini G; Kapp ME; Wheeler FC; Hopp L; Fogo AB
Hum Pathol; 2018 Nov; 81():229-234. PubMed ID: 29530752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
